Page last updated: 2024-09-04

moxifloxacin and midostaurin

moxifloxacin has been researched along with midostaurin in 1 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(midostaurin)
Trials
(midostaurin)
Recent Studies (post-2010) (midostaurin)
3,1575521,69049136286

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)midostaurin (IC50)
Aurora kinase AHomo sapiens (human)0.08
Macrophage colony-stimulating factor 1 receptorHomo sapiens (human)0.142
Mast/stem cell growth factor receptor KitHomo sapiens (human)0.109
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.25
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.1663
Aspartyl/asparaginyl beta-hydroxylaseHomo sapiens (human)7.5767
AP2-associated protein kinase 1Homo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
del Corral, A; Dutreix, C; Harrell, R; Huntsman-Labed, A; Lorenzo, S; Morganroth, J; Wang, Y1

Trials

1 trial(s) available for moxifloxacin and midostaurin

ArticleYear
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Aza Compounds; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Protein Kinase Inhibitors; Quinolines; Staurosporine; Young Adult

2012